Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer

BACKGROUND: Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges. METHODS: The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using un...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jinhua, Han, Zeping, Luo, Wenfeng, Shen, Jian, Xie, Fangmei, Liao, Liyin, Zou, Ge, Luo, Xin, Guo, Zhonghui, Li, Yuguang, Li, Jianhao, Chen, Hanwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846500/
https://www.ncbi.nlm.nih.gov/pubmed/36685547
http://dx.doi.org/10.3389/fimmu.2022.998447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846500/
https://www.ncbi.nlm.nih.gov/pubmed/36685547
http://dx.doi.org/10.3389/fimmu.2022.998447

Ejemplares similares